Top compounds associated with response to GDI1


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.25 2e-11
mRNA navitoclax:sorafenib (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 3e-08
mRNA BRD8899 CTRPv2 pan-cancer AAC 0.21 9e-08
mRNA Cetuximab GDSC1000 pan-cancer AAC -0.18 1e-07
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.2 1e-07
mRNA BIX-01294 CTRPv2 pan-cancer AAC 0.19 2e-07
mRNA necrosulfonamide CTRPv2 pan-cancer AAC 0.2 4e-07
mRNA ABT-263 CTRPv2 pan-cancer AAC 0.19 5e-07
mRNA PD-0325901 CCLE pan-cancer AAC -0.22 5e-07
mRNA navitoclax:piperlongumine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.19 8e-07
Download CSV